Praxis Precision Medicines
(NASDAQ) PRAX
Praxis Precision Medicines Financials at a Glance
Market Cap
$8.88BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$0.00
Net Income (TTM)
-$326.53M
EPS (TTM)
-$13.38
P/E Ratio
-23.81
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Price
$315.38
Volume
401,165.844
Open
$319.04
Price
$315.38
Volume
401,165.844
Open
$319.04
Previous Close
$313.50
Daily Range
$312.24 - $324.83
52-Week Range
$37.19 - $366.52
Estimated Earnings Date
Aug 3, 2026
Dividend
$0.00
Beta (Volatility)
0.87 (Low)
Price
$315.38
Volume
401,165.844
Open
$319.04
Previous Close
$313.50
Daily Range
$312.24 - $324.83
52-Week Range
$37.19 - $366.52
Estimated Earnings Date
Aug 3, 2026
PRAX News
PRAX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Praxis Precision Medicines
Industry
Biotechnology
Sector
Health CareEmployees
168
CEO
Marcio Souza, MBA
Website
www.praxismedicines.comHeadquarters
Boston, MA 02110, US
PRAX Financials
Key Financial Metrics (TTM)
Gross Margin
0.00%
Operating Margin
0.00%
Net Income Margin
0.00%
Return on Equity
-43.02%
Return on Capital
-37.14%
Return on Assets
-22.36%
Earnings Yield
-4.20%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$8.88BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
27.88M
Volume
401.17K
Avg. Volume
495.87K
Financials (TTM)
Gross Profit
-$128.84M
Operating Income
-$357.33M
EBITDA
-$326.40M
Operating Cash Flow
-$282.72M
Capital Expenditure
-$182.00K
Free Cash Flow
-$282.91M
Cash & ST Invst.
$786.87M
Total Debt
$1.44M
Praxis Precision Medicines Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
-$39.00K
+99.9%
Gross Margin
0.00%
N/A
Market Cap
$8.88BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$76.55M
N/A
Employees
116
N/A
Net Income
-$92.56M
-33.6%
EBITDA
-$92.52M
-33.6%
Quarterly Fundamentals
Total Cash
$786.87M
+139.9%
Total Debt
$1.44M
+34.6%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$1.44M
+34.6%
Return on Assets
-22.36%
N/A
Return on Invested Capital
-25.34%
N/A
Free Cash Flow
-$86.11M
-63.4%
Operating Cash Flow
-$86.05M
-63.3%